Director, Patient Advocacy, International

Mavericks Wanted

When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on

In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare

disease, and

develop life-changing medicines for patients with unmet needs as fast as humanly possible.

Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll

ask

"why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.

About BridgeBio

BridgeBio is a biopharmaceutical company dedicated to discovering, developing, and delivering transformative medicines for patients living with genetic diseases and genetically defined cancers. Since our founding in 2015, we have built a diverse portfolio of more than 20 drug development programs, ranging from early discovery to late-stage clinical trials, across multiple therapeutic areas including precision oncology, cardiology, endocrinology, neurology, and renal disease. We have already achieved regulatory approval for three therapies and continue to advance promising science from academia into meaningful treatments for patients worldwide.

Who We Are

BridgeBio is a global biotechnology company with our Global Headquarters located in San Francisco, USA, and our International HQ located in Zug, Switzerland. Since establishing our European presence in 2021, we’ve been building empowered, high-performing teams across countries — experienced colleagues who move quickly, take ownership, and are fueling the company’s international growth. At BridgeBio, you’ll find an energetic and collaborative culture where pragmatism meets bold decision-making. We embrace uncertainty with confidence, guided by our commitment to making a meaningful impact for patients. Our people are trusted and empowered, united by urgency, purpose, and the drive to advance science for patients around the world.

What You'll Do

The Director, Patient Advocacy, for Hypoparathyroidism leads the development and execution of Calcilytix’s patient advocacy strategy in support of clinical development and commercialization, while safeguarding long-term patient trust and community relationships. Reporting to the Senior Director of Global Patient Advocacy for Calcilytix, this role drives engagement across the International Hypoparathyroidism community, ensuring community insights inform company strategy and decision-making.

The Director oversees external international partnerships and educational initiatives, strengthening meaningful outreach across the region. As a strategic cross-functional partner, this leader collaborates with clinical development, medical affairs, commercial, and market access teams to integrate authentic patient perspectives into planning and execution.

The role

also champions a patient-focused culture within the international organization by elevating international community insights and ensuring regional perspectives inform strategy. Resposanbilities Develop and execute a comprehensive international patient advocacy and engagement strategy aligned with the Calcilytix hypoparathyroidism portfolio, ensuring patient and community insights meaningfully inform clinical development and commercialization planning. Serve as the primary liaison to international advocacy organizations, establishing and strengthening compliant, long-term relationships built on trust, transparency, and alignment. Integrate the patient voice across the product lifecycle, determining the appropriate timing and approach for engagement activities (e.g., advisory boards, patient organization summits, surveys, protocol input, patient-facing materials, community initiatives) in alignment with key development milestones. Translate community insights into actionable guidance for cross-functional partners, including clinical development, medical affairs, regulatory, and commercial teams. Support launch readiness and post-marketing activities, ensuring patient needs, access considerations, and real-world experiences meaningfully inform planning and execution. Lead strategic planning and oversight of advocacy-related budgets, including grants, sponsorships, advisory engagements, and educational initiatives. Champion a patient-centered culture across the international organization by embedding the voice of international patients and caregivers into internal communications, programming, and regional initiatives. Maintain expertise in relevant healthcare policy and industry regulations governing patient advocacy engagement and ensure compliant execution of all external activities. Demonstrate strong executive presence and leadership, serving as a trusted advisor internally and externally while representing Calcilytix within the hypoparathyroidism community. The above job description documents the general nature and level of work but is not intended to be an exhaustive list of activities, duties, and responsibilities required of job incumbents. Therefore, job incumbents are expected to perform all other duties as assigned or required, as training and experience allow. Where You’ll Work This is an office-based role and requires in-office collaboration 2-3x per week in our Zug Office.

The role

requires up to 30% travel across Europe and internationally.

Who You Are

Bachelor’s degree required; advanced degree preferred. 8+ years of patient advocacy or c